PIK3CA mutational status in tissue & plasma as a prognostic tool in HR+/HER2-breast cancer (BC)

被引：0
|
作者：
Brage, Eduardo Teran
Mejorada, Rebeca Lozano
Francoso, Aline Rodrigues
Leon, Jose Antonio Munoz
Gutierrez, Alvaro Lopez
Figuero-Perez, Luis
Araujo, Daniel Morchon
Martinez, Maria Garijo
Ruiz, Jonnathan Roldan
Hernandez, Maria Mar Abad
de Salas, Magdalena Sancho
Sanchez, Emilio Fonseca
Sanchez, Cesar Augusto Rodriguez
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-13-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-13-12
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prognostic value of PIK3CA mutational status in tissue & plasma in HR+/HER2-breast cancer (BC)
    Lozano Mejorada, R.
    Teran Brage, E.
    Munoz Leon, J. A.
    Lopez Gutierrez, A.
    Figuero Perez, L.
    Rodrigues Francoso, A.
    Seijas Tamayo, R.
    Morchon Araujo, D.
    Garijo Martinez, M. D. C.
    Roldan-Ruiz, J.
    Abad Hernandez, M. M.
    Sancho de Salas, M.
    Fonseca Sanchez, E.
    Rodriguez Sanchez, C. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S389 - S389
  • [2] PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2-breast cancer
    Teran, Eduardo
    Lozano, Rebeca
    Rodriguez, Cesar A.
    Abad, Mar
    Figuero, Luis
    Munoz, Jose Antonio
    Cigarral, Belen
    Rodrigues, Aline
    Sancho, Magdalena
    Gomez, M. Asuncion
    Morchon, Daniel
    Montero, Juan Carlos
    Sayagues, Jose Maria
    Ludena, M. Dolores
    Fonseca, Emilio
    CANCER MEDICINE, 2024, 13 (17):
  • [3] Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue
    Vollbrecht, Claudia
    Hoffmann, Inga
    Lehmann, Annika
    Merkelbach-Bruse, Sabine
    Fassunke, Jana
    Wagener-Ryczek, Svenja
    Ball, Markus
    Dimitrova, Lora
    Hartmann, Arndt
    Stohr, Robert
    Erber, Ramona
    Weichert, Wilko
    Pfarr, Nicole
    Bohlmann, Lisa
    Jung, Andreas
    Dietmaier, Wolfgang
    Dietel, Manfred
    Horst, David
    Hummel, Michael
    VIRCHOWS ARCHIV, 2023, 482 (04) : 697 - 706
  • [4] Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue
    Claudia Vollbrecht
    Inga Hoffmann
    Annika Lehmann
    Sabine Merkelbach-Bruse
    Jana Fassunke
    Svenja Wagener-Ryczek
    Markus Ball
    Lora Dimitrova
    Arndt Hartmann
    Robert Stöhr
    Ramona Erber
    Wilko Weichert
    Nicole Pfarr
    Lisa Bohlmann
    Andreas Jung
    Wolfgang Dietmaier
    Manfred Dietel
    David Horst
    Michael Hummel
    Virchows Archiv, 2023, 482 : 697 - 706
  • [5] A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
    Mollon, Lea E.
    Anderson, Elizabeth J.
    Dean, Joni L.
    Warholak, Terri L.
    Aizer, Ayal
    Platt, Emma A.
    Tang, Derek H.
    Davis, Lisa E.
    CLINICAL BREAST CANCER, 2020, 20 (03) : E232 - E243
  • [6] Association between PIK3CA mutation status and development of brain metastases in HR+/HER2-metastatic breast cancer
    Fitzgerald, D. M.
    Muzikansky, A.
    Pinto, C.
    Henderson, L.
    Walmsley, C.
    Allen, R.
    Ferraro, G. B.
    Isakoff, S.
    Moy, B.
    Oh, K.
    Shih, H. A.
    Dias-Santagata, D.
    Iafrate, A. J.
    Bardia, A.
    Brastianos, P. K.
    Juric, D.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
    Dandachi, N.
    Graf, R.
    Pancheri, L.
    Dobric, N.
    Klocker, E. V.
    Suppan, C.
    Jost, P. J.
    Heitzer, E.
    Balic, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1162 - S1163
  • [8] PIK3CA mutation status, progression and survival in advanced HR +/HER2-breast cancer: a meta-analysis of published clinical trials
    Fillbrunn, Mirko
    Signorovitch, James
    Andre, Fabrice
    Wang, Iris
    Lorenzo, Ines
    Ridolfi, Antonia
    Park, Jinhee
    Dua, Akanksha
    Rugo, Hope S.
    BMC CANCER, 2022, 22 (01)
  • [9] PIK3CA Mutation Assessment in HR+/HER2-Metastatic Breast Cancer: Overview for Oncology Clinical Practice
    Criscitiello, Carmen
    Marra, Antonio
    Curigliano, Giuseppe
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (01): : 42 - 54
  • [10] A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2-Metastatic Breast Cancer
    Anderson, Elizabeth J.
    Mollon, Lea E.
    Dean, Joni L.
    Warholak, Terri L.
    Aizer, Ayal
    Platt, Emma A.
    Tang, Derek H.
    Davis, Lisa E.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2020, 2020
12345